Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01041196 · ClinicalTrials.gov registry record

Perforated Marginal Ulcer After Gastric Bypass

A clinical trial of Marginal Ulcer and Ulcer Disease After Gastric Bypass, sponsored by University of California, San Francisco.

Completed
Registry status
30
Enrollment target
1
Study location

NCT01041196 is a study of Marginal Ulcer and Ulcer Disease After Gastric Bypass that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01041196, a study of Marginal Ulcer and Ulcer Disease After Gastric Bypass, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

A common late complication after gastric bypass surgery is marginal ulceration that is defined as ulcers at the margins of the gastrojejunostomy, mostly on the jejunal side. Most marginal ulcers respond to medical therapy and complicated or complex ulcer disease warrants operative intervention; specifically, perforated, penetrated, obstructing, bleeding and intractable marginal ulcers require surgical intervention. Diverse operative strategies for addressing perforated marginal ulcers after gastric bypass have been described including I) Omental (Graham) patch repair, II) Revision of gastrojejunostomy, III) Irrigation and drainage, IV) any previous procedure with truncal vagotomy, V) Esophagojejunostomy, and VI) Reversal. We formally analyze our experience with the laparoscopic resection and repair of acutely perforated marginal ulcers after Roux-en-Y gastric bypass (RYGB), with or without concomitant resolution of technical risk factors for marginal ulceration.

Study Locations (1)

California

  • UCSF Fresno Center for Medical Education and Research - Fresno

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-01
Est. Completion 2009-12

What the Registry Record Tells You About NCT01041196

The ClinicalTrials.gov registry entry for NCT01041196 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Marginal Ulcer appearing as the primary indexed condition, and to 0 interventions.

NCT01041196 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01041196 about?

NCT01041196 is a clinical study titled "Perforated Marginal Ulcer After Gastric Bypass". A common late complication after gastric bypass surgery is marginal ulceration that is defined as ulcers at the margins of the gastrojejunostomy, mostly on the jejunal side. Most marginal ulcers respond to medical therapy and complicated or complex ulcer disease warrants operative intervention; spec...

What is the current status of trial NCT01041196?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2009-12.

What conditions does trial NCT01041196 study?

This clinical trial studies the following conditions: Marginal Ulcer, Ulcer Disease After Gastric Bypass, Perforated Marginal Ulcer, Acutely Perforated Marginal Ulcer.

Who is sponsoring clinical trial NCT01041196?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01041196 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Marginal Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.